Logo image of KEQU

KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

NASDAQ:KEQU - Nasdaq - US4928541048 - Common Stock - Currency: USD

34.265  +0.33 (+0.96%)

Fundamental Rating

4

Taking everything into account, KEQU scores 4 out of 10 in our fundamental rating. KEQU was compared to 191 industry peers in the Health Care Equipment & Supplies industry. KEQU has an average financial health and profitability rating. KEQU has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

KEQU had positive earnings in the past year.
In the past year KEQU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.29%, KEQU belongs to the top of the industry, outperforming 91.62% of the companies in the same industry.
Looking at the Return On Equity, with a value of 28.92%, KEQU belongs to the top of the industry, outperforming 98.43% of the companies in the same industry.
KEQU has a Return On Invested Capital of 8.35%. This is amongst the best in the industry. KEQU outperforms 89.53% of its industry peers.
Industry RankSector Rank
ROA 9.29%
ROE 28.92%
ROIC 8.35%
ROA(3y)3.12%
ROA(5y)-0.07%
ROE(3y)6.34%
ROE(5y)-0.44%
ROIC(3y)N/A
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

KEQU has a Profit Margin of 7.99%. This is amongst the best in the industry. KEQU outperforms 81.15% of its industry peers.
In the last couple of years the Profit Margin of KEQU has grown nicely.
The Operating Margin of KEQU (6.73%) is better than 74.87% of its industry peers.
In the last couple of years the Operating Margin of KEQU has grown nicely.
KEQU has a Gross Margin of 27.02%. This is in the lower half of the industry: KEQU underperforms 76.96% of its industry peers.
KEQU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.73%
PM (TTM) 7.99%
GM 27.02%
OM growth 3YN/A
OM growth 5Y44.33%
PM growth 3YN/A
PM growth 5Y55.17%
GM growth 3Y16.23%
GM growth 5Y8.16%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

4

2. Health

2.1 Basic Checks

KEQU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, KEQU has more shares outstanding
Compared to 5 years ago, KEQU has more shares outstanding
Compared to 1 year ago, KEQU has an improved debt to assets ratio.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

KEQU has an Altman-Z score of 2.64. This is not the best score and indicates that KEQU is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of KEQU (2.64) is better than 67.02% of its industry peers.
KEQU has a debt to FCF ratio of 17.20. This is a negative value and a sign of low solvency as KEQU would need 17.20 years to pay back of all of its debts.
KEQU has a Debt to FCF ratio of 17.20. This is in the better half of the industry: KEQU outperforms 71.73% of its industry peers.
KEQU has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of KEQU (1.04) is worse than 73.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 17.2
Altman-Z 2.64
ROIC/WACC0.94
WACC8.91%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

KEQU has a Current Ratio of 2.16. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
KEQU's Current ratio of 2.16 is on the low side compared to the rest of the industry. KEQU is outperformed by 60.73% of its industry peers.
KEQU has a Quick Ratio of 1.54. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of KEQU (1.54) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.54
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.63% over the past year.
The Earnings Per Share has been growing by 64.49% on average over the past years. This is a very strong growth
The Revenue has grown by 9.44% in the past year. This is quite good.
The Revenue has been growing slightly by 6.81% on average over the past years.
EPS 1Y (TTM)99.63%
EPS 3YN/A
EPS 5Y64.49%
EPS Q2Q%28.24%
Revenue 1Y (TTM)9.44%
Revenue growth 3Y11.37%
Revenue growth 5Y6.81%
Sales Q2Q%43.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.80, the valuation of KEQU can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 98.43% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.92, KEQU is valued rather cheaply.
Industry RankSector Rank
PE 5.8
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaply inside the industry as 94.24% of the companies are valued more expensively.
KEQU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KEQU is cheaper than 83.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.09
EV/EBITDA 8.13
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KEQU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (4/24/2025, 8:21:33 PM)

34.265

+0.33 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)06-24 2025-06-24
Inst Owners44.09%
Inst Owner Change0%
Ins Owners16.11%
Ins Owner Change-4.29%
Market Cap97.66M
Analysts82.86
Price TargetN/A
Short Float %2.17%
Short Ratio1.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.8
Fwd PE N/A
P/S 0.44
P/FCF 25.09
P/OCF 14.98
P/B 1.61
P/tB 3.43
EV/EBITDA 8.13
EPS(TTM)5.91
EY17.25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.37
FCFY3.99%
OCF(TTM)2.29
OCFY6.68%
SpS77.2
BVpS21.33
TBVpS9.98
PEG (NY)N/A
PEG (5Y)0.09
Profitability
Industry RankSector Rank
ROA 9.29%
ROE 28.92%
ROCE 10.66%
ROIC 8.35%
ROICexc 8.96%
ROICexgc 11.91%
OM 6.73%
PM (TTM) 7.99%
GM 27.02%
FCFM 1.77%
ROA(3y)3.12%
ROA(5y)-0.07%
ROE(3y)6.34%
ROE(5y)-0.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y44.49%
ROICexc growth 3YN/A
ROICexc growth 5Y44.49%
OM growth 3YN/A
OM growth 5Y44.33%
PM growth 3YN/A
PM growth 5Y55.17%
GM growth 3Y16.23%
GM growth 5Y8.16%
F-Score5
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 17.2
Debt/EBITDA 3.35
Cap/Depr 65.66%
Cap/Sales 1.19%
Interest Coverage 250
Cash Conversion 34.65%
Profit Quality 22.14%
Current Ratio 2.16
Quick Ratio 1.54
Altman-Z 2.64
F-Score5
WACC8.91%
ROIC/WACC0.94
Cap/Depr(3y)117.83%
Cap/Depr(5y)107.18%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.63%
EPS 3YN/A
EPS 5Y64.49%
EPS Q2Q%28.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.44%
Revenue growth 3Y11.37%
Revenue growth 5Y6.81%
Sales Q2Q%43.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.94%
EBIT growth 3YN/A
EBIT growth 5Y54.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y130.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.01%
OCF growth 3Y178.06%
OCF growth 5Y51.03%